
March 2014
Advertisement
Advertisement
Trending on AJMC
1
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
2
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
3
United Therapeutics Plans FDA Submission for Inhaled Treprostinil in IPF
4
HDV Combo Shows No Relapses at 2 Years: Tarik Asselah, MD, PhD
5